Trial intelligence / Profile preview

PCV-free Rotarix vs standard Rotarix in Chinese infants

CTR20231898Phase 3Completed

Sponsor
GSK
Start
Jun 2023
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea, sponsored by GSK. Started Jun 2023; status: completed.

02

Drugs

human rotavirus RIX4414 strain vaccine
03

Conditions

rotaviral diarrhea

Beyond the preview

Go deeper on CTR20231898.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20231898.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call